Remus Pharmaceuticals Limited
Share Price Target & Analysis
NSE:REMUS
VWAP
Open
Close
High
Low
52 Week High
-20.60 (-2.29%)
REMUS
(PHARMA)Sideways to Positive
52 Week Low
EPS
PE
PB
Economical
Quality
Gold
Valuation
#Analysis
NSE: REMUS Share Price Financial Analysis & Valuation
Remus Pharmaceuticals Limited (REMUS) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals & Drugs vertical.
It is one of Micro Cap company with Market Capitalization of Rs 0 (in Cr). Total number of free float shares are 0 (in Lacs).
Remus Pharmaceuticals Limited is listed on NSE with Exchange ID - INE0O5T01011 and trading code is NSE:REMUS with short name Remus Pharma.
In the past 1 year, Remus Pharmaceuticals Limited has declared an equity dividend of Rs 0.06 per share. At the current share price of REMUS at Rs 880.60, this results in a dividend yield of 0.01 %.
As per the Fundamental Analysis of NSE:REMUS, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine REMUS underlying value and future prospects. All of this data is available in REMUS financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:REMUS, it is clearly understood that REMUS is Economical performer in terms of earnings and profit margins with an EPS of 23.29. NSE:REMUS book value per share as of today is 276.4. The current price to book ratio for REMUS as of Oct 24, 2026 is 3.19.
Valuation of the Stock: The current valuation of REMUS stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of REMUS whether to BUY this stock at current valuation. The delivery percentage of REMUS is 2700% is very crucial parameter which shows that 2700% investors are anticipating that the price of REMUS share should go up with VWAP at 875.
Now, the main question is whether to BUY or SELL, NSE:REMUS at current valuation.
As per latest Analysis No. #1632:-
⇑ STRONG BUY REMUS if All Greens
⇗ BUY REMUS (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD REMUS (With Stop Loss) if only 1 Green
⇘ SELL REMUS if NO Green Indicator
NSE: REMUS Share Price Today (Oct 24, 2026)
(Remus Pharmaceuticals Limited Daily Analysis on the basis of REMUS Intraday Graph & Trend)
Remus Pharmaceuticals Limited share price moved Down by -2.29% from its previous close of Rs 901.2. REMUS stock last traded price is 880.60. REMUS share price trend is Down with a total of 2800 stocks traded till now. It has touched an intraday high of Rs 890 and an intraday low of Rs 860. The REMUS trading at 880.60, Down by Rs. -20.60, or -2.29 percent which suggests that most of the Traders are anticipating that the price of REMUS share should go Down.
NSE: REMUS Share Price Tomorrow Prediction
(Remus Pharmaceuticals Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of REMUS)
Remus Pharmaceuticals Limited share price moved Down by -2.29%. REMUS share price short term trend is Down. It suggests that REMUS Share Price for Tomorrow remains the same with VWAP at 875 will be treated as stop loss for intraday traders. Remus Pharmaceuticals Limited Long term investors can follow the REMUS long term trend as mentiond in future forecast table.
NSE Code |
NSE: REMUS |
REMUS Share Price Today |
880.60 |
REMUS Share Price Target Prediction for 2026 ^ |
778.5 - 1044.1 |
REMUS Share Price Target Prediction for 2027*^ |
1044.1 - 1112.4 |
REMUS Share Price Target Prediction for 2028*^ |
1112.4 - 1190.3 |
REMUS Share Price Target Prediction for 2029*^ |
1250 |
REMUS Share Price Target Prediction for 2030*^ |
1286 |
REMUS Share Price Target Prediction for 2035*^ |
1401 |
| REMUS Current Book Value |
275 |
*Remus Pharmaceuticals Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^REMUS share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
REMUS Technical Analysis
Candlestick Pattern: @928.85| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 900.9 | BUY | 906.93 | BUY |
| MA_12 | 902.29 | BUY | 898.2 | BUY |
| MA_20 | 904.88 | BUY | 886.89 | BUY |
| MA_32 | 850.43 | BUY | 861.75 | BUY |
| MA_50 | 816.37 | BUY | 838.26 | BUY |
| MA_100 | 791.01 | BUY | 802.56 | BUY |
| MA_200 | 727.53 | BUY | 846.3 | BUY |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 904.88 | Uptrend |
| MACD | -4.7 | SELL |
| ADX | 18.04 | NO or Weak Trend |
| DMI (+/-) | 24.48 / 20.01 | Uptrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 60.96 | Neutral |
| STOCHASTIC_K (Fast) | 91.63 | Overbought |
| STOCHASTIC_D (Slow) | 63.27 | Neutral |
| CCI | 36.51 | Neutral |
| PSAR | 935.08 | SELL |
| TRUE RANGE | 37.5 | BUY |
| ATR | 35 | BUY |
| WILLIAMS R | -48.27 | Neutral |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 100 | Overbought |
| STOCHASTIC RSI D | 75.97 | Neutral |
| MOMENTUM | 80.15 | BUY |
| Duration | Value |
|---|---|
| 1 Year | 3.98% |
| 3 Months | 34.57% |
| 1 Month | 9.44% |
| 1 Week | 4.92% |
| Action | Overall (%) |
|---|---|
| BUY | 70% |
| NEUTRAL / HOLD | 23% |
| SELL | 7% |
(powered by Zerodha)
Most popular Questions & Answers about REMUS
Remus Pharmaceuticals Limited Frequently Asked Questions (FAQs)Remus Pharmaceuticals Limited stock last traded price is 880.60. REMUS share price moved Down by -2.29% from its previous close of Rs 901.2.
Remus Pharmaceuticals Limited share price trend is Down with a total of 2800 stocks traded till now. It has touched an intraday high of Rs 1049.39 and an intraday low of Rs 860. The REMUS trading at 880.60, Down by Rs. -20.60, or -2.29 percent which suggests that most of the Traders are anticipating that the price of REMUS share should go Down and the Stop Loss will be around 875.
The market cap of Remus Pharmaceuticals Limited is ₹0 (in Cr) as of Oct 23, 2026.
The current price to earning ratio for Remus Pharmaceuticals Limited as of Oct 23, 2026 is 41.99.
The current price to book ratio for Remus Pharmaceuticals Limited as of Oct 23, 2026 is 3.19.
The highest price of Remus Pharmaceuticals Limited stock is ₹1039 in the last 52-week.
The lowest price of Remus Pharmaceuticals Limited stock is ₹580 in the last 52-week.
Remus Pharmaceuticals Limited share trading at ₹880.60, Down by Rs. -20.60, or -2.29 percent which suggests that most of the traders are anticipating that the price of REMUS share should go Down.
In 2026, Stock price target for Remus Pharmaceuticals Limited (REMUS) will be around ₹778.5 on downside and ₹1044.1 on upside. Remus Pharmaceuticals Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Remus Pharmaceuticals Limited (REMUS) will be around ₹1044.1 on downside and ₹1112.4 on upside. Remus Pharmaceuticals Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Remus Pharmaceuticals Limited (REMUS) will be around ₹1112.4 on downside and ₹1190.3 on upside. Remus Pharmaceuticals Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Remus Pharmaceuticals Limited (REMUS) will be around ₹1286 Remus Pharmaceuticals Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of REMUS.
The price of Remus Pharmaceuticals Limited (REMUS) shares moved by -2.29%. The short-term trend for REMUS share price is Down. It implies that the share price of REMUS will stay the same tomorrow and that intraday traders should treat VWAP at 875 as a stop loss. Investors with a long-term outlook can track REMUS long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of REMUS stock is 279.2. Compared to the current market price of 880.60 INR, the REMUS stock is Overvalued by 68.3%.
As per the fundamental analysis of Remus Pharmaceuticals Limited (REMUS), it is of Economical quality in terms of earnings and profit margins with an EPS of 23.29. Remus Pharmaceuticals Limited book value per share as of today is 276.4. The current price to book ratio for REMUS as of Oct 24, 2026 is 3.19.
NSE:REMUS News & Other Useful Information about REMUS Share Price
Peer Comparison of NSE: REMUS
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals & Drugs
| Company | Price | EPS | BV |
|---|---|---|---|
| ZYDUSLIFE | 1129.40 | 40.96 | 238.63 |
| GLAND | 2826.80 | 89.58 | 677.19 |
| CADILAHC | 1129.40 | 40.96 | 238.63 |
| MADHAVBAUG | 146.45 | 10.03 | 61.48 |
| SUVENPHAR | 376.20 | 11.05 | 115.25 |
| ERIS | 1095.50 | 29.16 | 233.81 |
| PGHL | 5015.00 | 211.15 | 373.93 |
| SYMBIOTEC | 1164.20 | 4.53 | 105.01 |
| GLS | 1350.20 | 49.12 | 284.45 |
| SUPRIYA | 818.55 | 29.51 | 151.81 |
| SIGACHI | 25.11 | -1.7 | 12.62 |
| SAKAR | 889.80 | 24.29 | 150.48 |
| ORTINLAB | 14.93 | 0 | 1.11 |
| WALPAR | 26.10 | 2.55 | 18.08 |
| JSLL | 341.55 | 21.7 | 42.88 |
| JFLLIFE | 10.30 | 2.27 | 12.12 |
| MANKIND | 2212.60 | 59.75 | 410.5 |
| SOTAC | 92.00 | 6.71 | 52.33 |
| REMUS | 880.60 | 23.29 | 276.4 |
| VILINBIO | 50.95 | 1.57 | 18.6 |
| SAROJA | 40.80 | 4.29 | 43 |
| VALIANTLAB | 128.43 | 1.44 | 60.62 |
| BLUEJET | 475.55 | 15.67 | 82.91 |
| ACCENTMIC | 592.50 | 20.63 | 114.84 |
| ZENITHDRUG | 39.45 | 5.83 | 43.69 |
| INNOVACAP | 987.30 | 21.16 | 160.54 |
| ENTERO | 1468.40 | 8.88 | 387.12 |
| EMCURE | 1770.40 | 51.69 | 206.15 |
| MEDIORG | 24.55 | -1.83 | 21.18 |
| AKUMS | 669.00 | 10.26 | 157.14 |